Veritas Pharma Inc. | Balance Sheet
Fiscal year is May-April. All values USD Thousands.
2015
2016
2017
2018
Cash & Short Term Investments
51.40
27.40
862.00
1,682.20
Total Accounts Receivable
-
12.60
47.70
106.20
Other Current Assets
13.70
53.50
357.30
333.20
Total Current Assets
65.00
93.40
1,267.00
2,121.60
Net Property, Plant & Equipment
-
-
39.50
285.50
Total Investments and Advances
-
399.20
-
-
Long-Term Note Receivable
-
-
-
151.70
Intangible Assets
-
-
1,155.60
1,232.50
Other Assets
348.40
-
310.90
-
Total Assets
413.50
492.60
2,772.90
3,791.30
ST Debt & Current Portion LT Debt
165.10
45.90
-
-
Other Current Liabilities
15.00
35.00
161.70
196.40
Total Current Liabilities
180.10
80.90
161.70
196.40
Total Liabilities
180.10
80.90
161.70
196.40
Common Equity (Total)
233.40
411.70
2,265.70
3,594.90
Total Shareholders' Equity
233.40
411.70
2,265.70
3,594.90
Total Equity
233.40
411.70
2,611.20
3,594.90
Liabilities & Shareholders' Equity
413.50
492.60
2,772.90
3,791.30
Accumulated Minority Interest
-
-
345.50
-
About Veritas Pharma
View Profile
